Evidence map›Paper›PMID 29186441›Full record

ArticleGlycobiology2018

Imaging specific cellular glycan structures using glycosyltransferases via click chemistry.

Zhengliang L Wu, Anthony D Person, Matthew Anderson, Barbara Burroughs, Timothy Tatge, Kshitij Khatri, Yonglong Zou, Lianchun Wang, Todd Geders, Joseph Zaia and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Glycobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Fluorescent Detection ofBioconjugate chemistry · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Zhengliang L WuR&D Systems, Inc. a Bio-techne Brand, 614 McKinley Place N.E., Minneapolis, MN 55413, USA.
Anthony D PersonR&D Systems, Inc. a Bio-techne Brand, 614 McKinley Place N.E., Minneapolis, MN 55413, USA.
Matthew AndersonR&D Systems, Inc. a Bio-techne Brand, 614 McKinley Place N.E., Minneapolis, MN 55413, USA.
Barbara BurroughsR&D Systems, Inc. a Bio-techne Brand, 614 McKinley Place N.E., Minneapolis, MN 55413, USA.
Timothy TatgeR&D Systems, Inc. a Bio-techne Brand, 614 McKinley Place N.E., Minneapolis, MN 55413, USA.
Kshitij KhatriCenter for Biomedical Mass Spectrometry, Boston University School of Medicine, 670 Albany Street, Boston, MA 02118, USA.
Yonglong ZouR&D Systems, Inc. a Bio-techne Brand, 614 McKinley Place N.E., Minneapolis, MN 55413, USA.
Lianchun WangComplex Carbohydrate Research Center, University of Georgia, Athens, GA 30602, USA.
Todd GedersR&D Systems, Inc. a Bio-techne Brand, 614 McKinley Place N.E., Minneapolis, MN 55413, USA.
Joseph ZaiaCenter for Biomedical Mass Spectrometry, Boston University School of Medicine, 670 Albany Street, Boston, MA 02118, USA.
Robert SacksteinDepartment of Dermatology and Department of Medicine, Brigham & Women's Hospital, Boston, MA, USA.
R&D Systems (United States) · USBoston University · USHarvard University · USUniversity of Georgia · US

Funding

REGULATION OF LACTOSAMINYL GLYCAN BIOSYNTHESIS IN HEMATOPOIETIC CELLSP01HL107146 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SACKSTEIN, ROBERT · 2011 to 2017
$17.7M
TR&D3. Approaches to Proteoglycan Function at Biochemical and Cellular LevelsP41GM103390 · NIGMS · UNIVERSITY OF GEORGIA · PI MOREMEN, KELLEY W. · 2012 to 2019
$14.5M
Robo4 and heparan sulfate proteoglycan in angiogenesisR01HL093339 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI WANG, LIANCHUN · 2009 to 2018
$3.4M
Using CRISPR-Cas9 technology to develop a mutant cell library for heparan sulfate structure-function studyR21HL131553 · NHLBI · UNIVERSITY OF GEORGIA · PI WANG, LIANCHUN · 2015 to 2016
$582k
NHLBI NIH HHS P01 HL107146NHLBI NIH HHS R01 HL093339NHLBI NIH HHS R21 HL131553NIGMS NIH HHS P41 GM103390
6 · The paper itself

Abstract

Heparan sulfate (HS) is a polysaccharide fundamentally important for biologically activities. T/Tn antigens are universal carbohydrate cancer markers. Here, we report the specific imaging of these carbohydrates using a mesenchymal stem cell line and human umbilical vein endothelial cells (HUVEC). The staining specificities were demonstrated by comparing imaging of different glycans and validated by either removal of target glycans, which results in loss of signal, or installation of target glycans, which results in gain of signal. As controls, representative key glycans including O-GlcNAc, lactosaminyl glycans and hyaluronan were also imaged. HS staining revealed novel architectural features of the extracellular matrix (ECM) of HUVEC cells. Results from T/Tn antigen staining suggest that O-GalNAcylation is a rate-limiting step for O-glycan synthesis. Overall, these highly specific approaches for HS and T/Tn antigen imaging should greatly facilitate the detection and functional characterization of these biologically important glycans.

Indexed as

AnimalsAntigensCell LineClick ChemistryExtracellular MatrixGlycosyltransferasesHeparan SulfateHumansHuman Umbilical Vein Endothelial CellsHyaluronic AcidMesenchymal Stem CellsMiceProtein Processing, Post-TranslationalAntigensGlycosyltransferasesHeparan SulfateHyaluronic Acidclick chemistryglycan imagingglycosyltransferaseheparan sulfateT antigen

Identifiers

PMID29186441
PMCPMC5993098
OpenAlexW2953222456

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.